Japanese drugmaker Takeda has announced positive topline results for two pivotal Phase III studies of zasocitinib (TAK-279), ...
UK pharma major GSK yesterday announced that the US Food and Drug Administration (FDA) has approved Exdensur ...
Sino-US biotech Harbour BioMed, which is focused on the discovery and development of novel antibody therapeutics in ...
US biotech Incyte yesterday revealed that the European Commission (EC) has approved Minjuvi (tafasitamab) in combination with ...
USA and Europe listed biotech PureTech has appointed Robert Lyne as chief executive (CEO), and as a member of the board of ...
US venture firm MBX Capital has crossed $100 million in cumulative capital commitments to invest in early-stage biotech and ...
Switzerland-based Topadur Pharma, a biotech company developing innovative therapies for vascular regeneration, has announced ...
German biotech T-CURX today announced the first closing of a $20 million (17.7 million) Series A financing with a syndicate ...
US drug distribution and services group Cencora (NYSE: COR) said it has agreed to accelerate its acquisition of a controlling ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new indication for Dutch immunology company ...
US clinical-stage oncology company NanOlogy has appointed David Arthur as chief executive, as it accelerates development of ...
A wave of transformative US drug-pricing agreements and record manufacturing investments from leading biopharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback